SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule
ARQL 20.000.0%Jan 16 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (85)7/18/1997 3:12:00 AM
From: Miljenko Zuanic   of 399
 
Cheers Rick, James!

Rick, No I don't think so. As you said they have enough good chemist, and I am *only* genius chemist. Also, my boss will immediately get hart attack. I will explain why to James by e-mail, and you can talk with him.

I agree that mid-level managers are important for projects care-forward. I trust James and you that they do have capability, I do not question technologies and money, for focus and to successful finish what they started.

James, I do not view ARQL collaborations as negative, for sure this is positive. Only I am bit concern, as Rick pointed, on possibility of the dilution regards the explosive grow.

Thanks to both.

Cheers, mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext